0.3150
+0.0742
+(30.81%)
At close: January 23 at 7:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-86,769.0000
-96,624.0000
-20,693.0000
1,155.0000
180,266.0000
Investing Cash Flow
8,073.0000
7,040.0000
11,050.0000
10,753.0000
-6,020.0000
Financing Cash Flow
43,683.0000
44,589.0000
360.0000
20,441.0000
-290.0000
End Cash Position
124,119.0000
162,602.0000
206,386.0000
216,231.0000
183,851.0000
Capital Expenditure
-188.0000
-1,902.0000
-2,675.0000
-871.0000
-99.0000
Issuance of Capital Stock
44,869.0000
45,697.0000
1,797.0000
21,182.0000
--
Free Cash Flow
-86,957.0000
-98,526.0000
-23,368.0000
284.0000
180,167.0000
12/31/2020 - 3/17/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NP5.DE Newron Pharmaceuticals S.p.A.
10.18
+3.14%
CALC CalciMedica, Inc.
2.5600
+0.79%
BRNS Barinthus Biotherapeutics plc
1.0953
+9.53%
ONCT Oncternal Therapeutics, Inc.
0.5266
-24.12%
GRTSQ Gritstone bio, Inc.
0.0010
0.00%
ONCO.CN Onco-Innova
2.0400
+6.81%
GRI GRI Bio, Inc.
0.6320
-3.76%
CANF Can-Fite BioPharma Ltd.
1.4800
-4.52%
JAZZ Jazz Pharmaceuticals plc
124.37
-0.54%
ALNY Alnylam Pharmaceuticals, Inc.
271.31
-2.11%